Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma

I Girault, C Andrieu, S Tozlu, F Spyratos, I Bieche, I Lidereau

Research output: Contribution to journalArticle (Academic Journal)peer-review

25 Citations (Scopus)

Abstract

Dysregulation of total estrogen receptor beta (ERbeta) expression has been implicated in breast tumorigenesis. The ERP gene yields five exon 8 alternatively spliced transcripts (ERbeta1-5), which encode proteins with different C-terminal amino acids. Individual expression analysis of these transcripts may provide new insights into estrogen signaling in breast cancer. We measured mRNA levels of total ERbeta and its five isoforms in normal tissues, breast carcinomas from post-menopausal patients, and breast cancer cell lines by means of real-time reverse transcription-polymerase chain reaction and fluorescent fragment analysis. In various normal human tissues, ERbeta1-5 isoforms displayed different qualitative and quantitative expression patterns that were consistent with previous reports. Total ERP mRNA levels were significantly lower in breast tumors than in normal breast tissues (38-fold lower, P
Translated title of the contributionAltered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma
Original languageEnglish
Pages (from-to)101 - 112
JournalCancer Letters
Volume215 (1)
Publication statusPublished - 8 Nov 2004

Bibliographical note

Publisher: Elsevier Sci Ireland Ltd
Other identifier: IDS Number: 860SX

Fingerprint Dive into the research topics of 'Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma'. Together they form a unique fingerprint.

Cite this